Cargando…

STAT1 modification improves therapeutic effects of interferons on lung cancer cells

BACKGROUND: Interferons (IFNs) have potent anti-proliferative, pro-apoptotic, and immunomodulatory activities against cancer. However, the clinical utility of IFNs is limited by toxicity and pharmacokinetics making it difficult to achieve sustained therapeutic levels especially in solid tumors. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Junjie, Zhao, Jialu, Chen, Lefu, Dong, Nian, Ying, Zhaojian, Cai, Zhenzhen, Ji, Dongxiang, Zhang, Yong, Dong, Li, Li, Yuping, Jiang, Lei, Holtzman, Michael J., Chen, Chengshui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562290/ https://www.ncbi.nlm.nih.gov/pubmed/26351076 http://dx.doi.org/10.1186/s12967-015-0656-0

Ejemplares similares

Lipopolysaccharide-induced CCN1 production enhances interleukin-6 secretion in bronchial epithelial cells
por: Shi, Lin, et al.
Publicado: (2017)

Potential therapeutic targets for hypoxia-induced pulmonary artery hypertension
por: Dong, Li, et al.
Publicado: (2014)

Epithelial-mesenchymal transition is associated with osteopontin-induced EGFR‑TKI resistance in EGFR mutant non-small cell lung cancer
por: Chen, Junjie, et al.
Publicado: (2023)

The Clinical Clues of Pulmonary Alveolar Proteinosis: A Report of 11 Cases and Literature Review
por: Mo, Qiongya, et al.
Publicado: (2016)

Evidence for the critical role of the PI3K signaling pathway in particulate matter-induced dysregulation of the inflammatory mediators COX-2/PGE(2) and the associated epithelial barrier protein Filaggrin in the bronchial epithelium
por: Song, Chenjian, et al.
Publicado: (2019)

Fibroblast growth factor 10 alleviates particulate matter-induced lung injury by inhibiting the HMGB1-TLR4 pathway
por: Liu, Lingjing, et al.
Publicado: (2020)

Clinical evaluation of a laboratory‐developed test using clone E1L3N for the detection of PD‐L1 expression status in non‐small cell lung cancer
por: Xu, Hanyan, et al.
Publicado: (2021)

Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
por: Li, Yuping, et al.
Publicado: (2017)

The regulation of inflammation by interferons and their STATs
por: Rauch, Isabella, et al.
Publicado: (2013)

Can glypican-3 be a disease-specific biomarker?
por: Chen, Chaolei, et al.
Publicado: (2017)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

Sphingosine 1-phosphate receptor 1 governs endothelial barrier function and angiogenesis by upregulating endoglin signaling
por: Wang, Beibei, et al.
Publicado: (2022)

Evidence for lung repair and regeneration in humans: key stem cells and therapeutic functions of fibroblast growth factors
por: Chu, Xuran, et al.
Publicado: (2019)

Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia
por: Chen, Chengshui, et al.
Publicado: (2016)

Responses to crizotinib and chemotherapy in patients with lung adenocarcinoma harboring a concomitant EGFR mutation and ALK gene rearrangement: A case report and review of the literature
por: Li, Yuping, et al.
Publicado: (2017)

Predictive diagnosis of chronic obstructive pulmonary disease using serum metabolic biomarkers and least‐squares support vector machine
por: Zheng, Hong, et al.
Publicado: (2020)

3C(pro) of FMDV inhibits type II interferon-stimulated JAK-STAT signaling pathway by blocking STAT1 nuclear translocation
por: Wu, Xiangju, et al.
Publicado: (2023)

Whole exome sequencing identified a novel POT1 variant as a candidate pathogenic allele underlying a Li–Fraumeni-like family
por: Li, Yuping, et al.
Publicado: (2022)

Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation
por: Bao, Lianmin, et al.
Publicado: (2016)

Fine-Tuning of Type I Interferon Response by STAT3
por: Tsai, Ming-Hsun, et al.
Publicado: (2019)

The Distribution Frequency of Interferon-Gamma Receptor 1 Gene Polymorphisms in Interferon-γ Release Assay-Positive Patients
por: Chen, Changguo, et al.
Publicado: (2017)

Lack of interferon regulatory factor 3 leads to anxiety/depression-like behaviors through disrupting the balance of neuronal excitation and inhibition in mice
por: Li, Junjie, et al.
Publicado: (2022)

Regulation of the linear ubiquitination of STAT1 controls antiviral interferon signaling
por: Zuo, Yibo, et al.
Publicado: (2020)

Nucleic DHX9 cooperates with STAT1 to transcribe interferon-stimulated genes
por: Ren, Xingxing, et al.
Publicado: (2023)

STAT3 signaling in ovarian cancer: a potential therapeutic target
por: Liang, Renba, et al.
Publicado: (2020)

Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process
por: Zheng, Hong, et al.
Publicado: (2021)

Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
por: Eskandarian Boroujeni, Mahdi, et al.
Publicado: (2022)

The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation
por: Liu, Hainan, et al.
Publicado: (2021)

STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α
por: Yamauchi, Shota, et al.
Publicado: (2016)

STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling
por: Arimoto, Kei-ichiro, et al.
Publicado: (2017)

P2RY13 Exacerbates Intestinal Inflammation by Damaging the Intestinal Mucosal Barrier via Activating IL-6/STAT3 Pathway
por: Wu, Xiaohan, et al.
Publicado: (2022)

Establishing a novel model of malignant airway stenosis in rabbit
por: Lin, Xiaoxiao, et al.
Publicado: (2022)

Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma
por: Xu, Zhixiao, et al.
Publicado: (2021)

RNA modification: mechanisms and therapeutic targets
por: Qiu, Lei, et al.
Publicado: (2023)

Interferon-alpha Induces High Expression of APOBEC3G and STAT-1 in Vitro and in Vivo
por: Chen, Hui, et al.
Publicado: (2010)

Small Molecule Inhibitors of Interferon‐Induced JAK‐STAT Signalling
por: Thoidingjam, Leishemba K., et al.
Publicado: (2022)

The Downregulation of PTGS2 Mediated by ncRNAs is Tightly Correlated with Systemic Sclerosis-Interstitial Lung Disease
por: Xu, Zhixiao, et al.
Publicado: (2022)

Zika virus NS2A inhibits interferon signaling by degradation of STAT1 and STAT2
por: Fanunza, Elisa, et al.
Publicado: (2021)

STAT3 exerts pro-tumor and anti-autophagy roles in cervical cancer
por: Wu, Lin, et al.
Publicado: (2022)

Editorial: Sepsis: Basic, Clinical and Therapeutic Approaches
por: Kang, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ibf0mf19vvntvsbf6cvi77fhrk